Skip to main content

LAMY Completes Strategic Acquisition of Cancer Therapy Innovator Exousia AI, Inc.

EXOUSIA AI SECURES HIGH-VALUE ORPHAN DRUG DESIGNATION ORLANDO, Fla., Dec. 02, 2025 (GLOBE NEWSWIRE) — LAMY, to become Exousia Bio, Inc. (OTCPINK: LMMY) (the “Company” or “Exo Bio”), operating as a leading U.S. biotechnology company focused on exosome-based cancer therapy, today announced the completion of the acquisition of 100% of Exousia AI, Inc. in an all-stock transaction. LAMY issued 62,223,000 restricted shares of its Common stock to finalize the deal, consolidating ownership of a highly promising preclinical oncology platform. Foundation Built on Exclusive, Worldwide Licensing The strategic acquisition reinforces Exousia Bio’s position as an innovator in the exosome space. The Company has secured two exclusive worldwide licenses for Exosome technology. These patented and patent-pending intellectual property rights...

Continue reading

LAMY Completes Strategic Acquisition of Cancer Therapy Innovator Exousia AI, Inc.

EXOUSIA AI SECURES HIGH-VALUE ORPHAN DRUG DESIGNATION ORLANDO, Fla., Dec. 02, 2025 (GLOBE NEWSWIRE) — LAMY, to become Exousia Bio, Inc. (OTCPINK: LMMY) (the “Company” or “Exo Bio”), operating as a leading U.S. biotechnology company focused on exosome-based cancer therapy, today announced the completion of the acquisition of 100% of Exousia AI, Inc. in an all-stock transaction. LAMY issued 62,223,000 restricted shares of its Common stock to finalize the deal, consolidating ownership of a highly promising preclinical oncology platform. Foundation Built on Exclusive, Worldwide Licensing The strategic acquisition reinforces Exousia Bio’s position as an innovator in the exosome space. The Company has secured two exclusive worldwide licenses for Exosome technology. These patented and patent-pending intellectual property rights...

Continue reading

Otus Acquires MindPrint Learning to Create the Industry’s Most Comprehensive K-12 Student Profile Solution

With the addition of MindPrint’s student learning profile and strengths-based instruction strategies, Otus equips teachers with even more insights and tools to maximize student growth across all subjects.Otus, the leading K-12 platform for student assessment, data, and insights, announced today the acquisition of MindPrint Learning, a company renowned for helping educators understand how students learn best and tailor instruction to their iThe acquisition, advised by Tucker Capital on behalf of MindPrint Learning, follows a successful multiyear partnership and advances Otus’ mission to provide educators with a comprehensive, unified view of every student.CHICAGO, IL, Dec. 02, 2025 (GLOBE NEWSWIRE) — Otus, the leading K-12 platform for student assessment, data, and insights, announced today the acquisition of MindPrint...

Continue reading

SciSparc: Neurothera Labs Signs Non-Binding Term Sheet to Acquire Majority Stake in a Quantum Algorithm Bio Data Analysis Company

TEL AVIV, Israel, Dec. 02, 2025 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) (“NeuroThera”), a clinical-stage pharmaceutical company focused on developing novel treatments for central nervous system disorders, in which SciSparc holds a controlling interest of approximately 75%, has entered into a non-binding term sheet (the “Term Sheet”) with an Israeli-based pioneering quantum computing bio data company focused on quantum-enabled clinical analytics (the “Target Company”). Pursuant to the Term Sheet, NeuroThera will acquire a 55% equity interest in the Target Company from certain selling shareholders of the Target Company (the “Selling Shareholders”), calculated on a post transaction fully diluted basis, in consideration for the...

Continue reading

Sonnet BioTherapeutics Holdings, Inc. Announces Stockholder Approval of Proposed Business Combination with Hyperliquid Strategies Inc

PRINCETON, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) — Sonnet BioTherapeutics Holdings, Inc., (NASDAQ: SONN) (“Sonnet” or the “Company”) today announced that its stockholders approved, among other things, the proposed business combination with Hyperliquid Strategies Inc (“HSI”) and Rorschach I LLC at its special meeting of stockholders. The final voting results for the special meeting will be filed in a Form 8-K with the U.S. Securities and Exchange Commission. About Sonnet BioTherapeutics Holdings, Inc. Sonnet BioTherapeutics Holdings, Inc. is an oncology-focused biotechnology company with a proprietary platform for innovating biologic drugs of single or bifunctional action. Known as FHAB (Fully Human Albumin Binding), the technology utilizes a fully human single chain antibody fragment (scFv) that binds to and “hitch-hikes” on human...

Continue reading

Quickbase Acquires Juiced Technologies

Acquisition will extend what’s possible in Quickbase and make it easier to get started with Juiced’s advanced add-ons BOSTON, Dec. 02, 2025 (GLOBE NEWSWIRE) — Quickbase, the AI operations platform, today announced that it has acquired Juiced Technologies (“Juiced”), a long-standing partner specializing in developing and hosting Quickbase add-ons. The acquisition will extend Quickbase’s native functionality with Juiced’s advanced document formatting capabilities and e-signature, geomapping, and email-to-text features. For more than two decades, Juiced has developed a suite of advanced, customizable add-ons that not only complement the core Quickbase platform, but also extend what’s possible for Quickbase users—designed with an intuitive user experience in mind. Its portfolio, including JuicedSign, Exact Forms Plus, QB Maps, XL...

Continue reading

Rio Silver Acquires Second High-Potential Silver-Lead-Zinc Project in Central Peru

Santa Rita acquisition expands Rio Silver’s district-scale presence with high-grade CRD mineralization, complementary geology to Maria Norte, and the infrastructure advantages needed to advance a near-term, pure-play silver development strategy in Peru VANCOUVER, British Columbia, Dec. 02, 2025 (GLOBE NEWSWIRE) — Rio Silver Inc. (TSX-V: RYO | OTC: RYOOF) (“Rio Silver” or the “Company”) is pleased to announce that its Peruvian subsidiary, Rio Plata S.A.C., has acquired the Santa Rita Pb-Zn-Ag Property, a highly prospective exploration target with extensive historical workings and strong silver-lead-zinc showings in Central Peru. A representative sample has been submitted for metallurgical testing, which is now underway. Historical work completed by previous operators has guided Rio Silver’s internal evaluation, and the Company will...

Continue reading

The Ensign Group Grows Operations in Colorado

SAN JUAN CAPISTRANO, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) — The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it acquired the operations of (i) “The Rehabilitation Center at Sandalwood”, a 103-bed skilled nursing facility located in Wheat Ridge, Colorado, and (ii) “Edgewater Health and Rehabilitation”, a 69-bed skilled nursing facility located in Lakewood, Colorado. Both facilities are subject to a long-term, triple net lease with a third-party landlord. This acquisition was effective as of December 1, 2025. “These two facilities were perfect additions to our recent growth in Colorado,”...

Continue reading

The Ensign Group Increases Operations in Arizona

SAN JUAN CAPISTRANO, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) — The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it acquired the operations of “Santa Rosa Care Center”, a 144-bed skilled nursing facility located in Tucson, Arizona which is subject to a long-term, triple net lease with a third-party landlord. This acquisition was effective as of December 1, 2025. “We are excited to add another operation to one of our more mature and thriving markets,” said Barry Port, Ensign’s Chief Executive Officer. “This facility clusters well with other operations in Tucson and we are looking forward...

Continue reading

The Ensign Group Adds Real Estate and Operations in Kansas

SAN JUAN CAPISTRANO, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) — The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it acquired the real estate and operations of “Willow Point Rehabilitation and Nursing Center”, a 45-bed skilled nursing facility located in Kansas City, Kansas. The real estate was acquired by a subsidiary of Standard Bearer Healthcare REIT, Inc., Ensign’s captive real estate company, and the facility is operated by an Ensign-affiliated tenant. The acquisition was effective as of December 1, 2025. “This is another fantastic addition to our portfolio in Kansas. This new facility...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.